lactic acid has been researched along with Enterocolitis, Pseudomembranous in 1 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Enterocolitis, Pseudomembranous: An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolla, PA | 1 |
| Carasi, P | 1 |
| Bolla, Mde L | 1 |
| De Antoni, GL | 1 |
| Serradell, Mde L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir[NCT02707198] | Phase 2 | 2 participants (Actual) | Interventional | 2015-11-30 | Terminated (stopped due to Study was not feasible to complete at study site) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for lactic acid and Enterocolitis, Pseudomembranous
| Article | Year |
|---|---|
Protective effect of a mixture of kefir-isolated lactic acid bacteria and yeasts in a hamster model of Clostridium difficile infection.
Topics: Administration, Oral; Animals; Bacterial Toxins; Cecum; Clostridioides difficile; Cricetinae; Cultur | 2013 |